- Home
- NGEN vs DOUG Comparison
NGEN vs DOUG Comparison
Compare NGEN & DOUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NGEN | DOUG |
|---|---|---|
| Founded | 2017 | 1911 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Building operators |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.5M | 178.2M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NGEN | DOUG |
|---|---|---|
| Price | $1.86 | $1.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 375.0K | 343.2K |
| Earning Date | 04-02-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 118.68 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $955,578,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.58 | $1.53 |
| 52 Week High | $5.93 | $3.19 |
Technical Indicators
Market Signals| Indicator | NGEN | DOUG |
|---|---|---|
| Relative Strength Index (RSI) | 57.39 | 56.52 |
| Support Level | $1.59 | $1.70 |
| Resistance Level | $2.22 | $2.10 |
| Average True Range (ATR) | 0.09 | 0.09 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 95.35 | 54.88 |
Price Performance
Historical ComparisonAbout NGEN NervGen Pharma Corp. Common stock
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is engaged in the real estate services business and seeks to acquire or invest in additional real estate services businesses. The Company also offers, through its subsidiaries and ventures, development marketing services and ancillary services, including mortgage, title, and escrow services. It generates revenue from commissions and other brokerage income, property management, and other ancillary services.